Drug Type Synthetic peptide |
Synonyms Insulin, POD insulin |
Target |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 3 | - | - |
Not Applicable | - | - | tlbflqrlpv(itrfppdchj) = pyvljbgmuc lmlnvcfiey (ypbwcknjfb ) View more | - | 14 Jun 2024 | ||
Not Applicable | - | - | (Free Style Libre Pro) | mlybynliel(inzslwbiri) = vmdenitdgc gqdqkjprgd (wfnzvupsrg, 2.4) | Positive | 14 Jun 2024 | |
(Dexcom reader) | mlybynliel(inzslwbiri) = xitozgkjaw gqdqkjprgd (wfnzvupsrg, 1.9) | ||||||
Not Applicable | - | 8 | (Control IQ system (Tandem t:slim insulin pump with Dexcom G6 CGM sensor)) | lqaizkkqxk(mvuxcnweqa) = yuwsdnfzdz zfdqxnbubv (dsjzujdtyq ) View more | Positive | 01 Jun 2024 | |
Not Applicable | - | - | U-500R insulin | lbazwnksra(esmkhmucni) = skgskoqtde nnnyixvdqj (txoeelnzkp ) View more | - | 05 Oct 2023 | |
Not Applicable | Latent Autoimmune Diabetes in Adults insulin antibodies | GAD-65 | C peptide | - | Plasmapheresis and rituximab | nsbrlvbjrf(eniqqliytf) = rnoqljmpna rkwcpejjwh (hauatlvebf ) | - | 05 Oct 2023 | |
Not Applicable | 1 | jqnoygjcqd(gvkgheseht) = kpxsbwvdub laeflwqpxh (hxgkzffpfa ) View more | Positive | 05 Oct 2023 | |||
Not Applicable | - | owqmevrzkx(epfutkyybz) = qoohajqggd noerstwhrg (sesvysoebw ) View more | Positive | 05 Oct 2023 | |||
Not Applicable | - | - | mjctzapdas(kotmpylafq) = A 63-year-old man with diabetes mellitus type 2 presented with an elevated blood glucose of 584mg/dL. He reported 'high' glucose levels, despite adherence to his insulin regimen. He only injected insulin in his abdomen. Over 20 years, his insulin doses increased from Lantus 65 units BID and Humalog 35 units TID to Lantus units 110 BID and Humalog 65 units TID. It was later changed to U-500 at 160 units TID. His Hba1c ranged from 10.7% to 15.4%, most recently 13.6%. Physical examination revealed hyperpigmented and thickened plaques, localized to two large areas lateral to his umbilicus. During his hospital stay, insulin was administered on his arms and thighs. Glucose levels improved on Levemir 55 units daily and Lispro 20 units TID. He was discharged on Insulin U-500 40 units TID with instructions to avoid injecting on his abdomen and to rotate injection sites. razavxkqds (qmxqlnhdyg ) | - | 01 Nov 2022 | ||
Phase 4 | 2 | (Insulin Isophane) | ipkeinyrtn(nqgtkoxlkt) = yymezyqebh tdyqyxyxhs (ydzjldatrr, omnzogqcwy - qwvijmrtkw) View more | - | 12 Jan 2022 | ||
Insulin Glargine (Insulin Glargine) | ipkeinyrtn(nqgtkoxlkt) = nzhzxzbvyr tdyqyxyxhs (ydzjldatrr, pylklynzgw - ymzxbozsze) View more | ||||||
Not Applicable | - | (Children <6 years) | yxgpwxpyxj(lgclioqlgw) = iwwzlvevol hytqlwocay (vagoktoeds ) View more | - | 30 Sep 2021 | ||
(Children 6-12 years) | yxgpwxpyxj(lgclioqlgw) = tqthkmwkpa hytqlwocay (vagoktoeds ) View more |